Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update
Issued Date
2024-04-01
Resource Type
ISSN
24681253
Scopus ID
2-s2.0-85186500271
Pubmed ID
38367629
Journal Title
The Lancet Gastroenterology and Hepatology
Volume
9
Issue
4
Start Page
346
End Page
365
Rights Holder(s)
SCOPUS
Bibliographic Citation
The Lancet Gastroenterology and Hepatology Vol.9 No.4 (2024) , 346-365
Suggested Citation
Cooke G.S., Flower B., Cunningham E., Marshall A.D., Lazarus J.V., Palayew A., Jia J., Aggarwal R., Al-Mahtab M., Tanaka Y., Jeong S.H., Poovorawan K., Waked I., Hiebert L., Khue P.M., Grebely J., Alcantara-Payawal D., Sanchez-Avila J.F., Mbendi C., Muljono D.H., Lesi O., Desalegn H., Hamid S., de Araujo A., Cheinquer H., Onyekwere C.A., Malyuta R., Ivanchuk I., Thomas D.L., Pimenov N., Chulanov V., Dirac M.A., Han H., Ward J.W. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update. The Lancet Gastroenterology and Hepatology Vol.9 No.4 (2024) , 346-365. 365. doi:10.1016/S2468-1253(23)00321-7 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/97618
Title
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update
Author(s)
Cooke G.S.
Flower B.
Cunningham E.
Marshall A.D.
Lazarus J.V.
Palayew A.
Jia J.
Aggarwal R.
Al-Mahtab M.
Tanaka Y.
Jeong S.H.
Poovorawan K.
Waked I.
Hiebert L.
Khue P.M.
Grebely J.
Alcantara-Payawal D.
Sanchez-Avila J.F.
Mbendi C.
Muljono D.H.
Lesi O.
Desalegn H.
Hamid S.
de Araujo A.
Cheinquer H.
Onyekwere C.A.
Malyuta R.
Ivanchuk I.
Thomas D.L.
Pimenov N.
Chulanov V.
Dirac M.A.
Han H.
Ward J.W.
Flower B.
Cunningham E.
Marshall A.D.
Lazarus J.V.
Palayew A.
Jia J.
Aggarwal R.
Al-Mahtab M.
Tanaka Y.
Jeong S.H.
Poovorawan K.
Waked I.
Hiebert L.
Khue P.M.
Grebely J.
Alcantara-Payawal D.
Sanchez-Avila J.F.
Mbendi C.
Muljono D.H.
Lesi O.
Desalegn H.
Hamid S.
de Araujo A.
Cheinquer H.
Onyekwere C.A.
Malyuta R.
Ivanchuk I.
Thomas D.L.
Pimenov N.
Chulanov V.
Dirac M.A.
Han H.
Ward J.W.
Author's Affiliation
Lagos University Teaching Hospital
Faculty of Tropical Medicine, Mahidol University
Mahidol Oxford Tropical Medicine Research Unit
St. Paul‘s Hospital Millennium Medical College
The National Medical Research Center of Phthisiopulmonology and Infectious Diseases under the Ministry of Health of the Russian Federation
Haiphong University
Instituto de Salud Global de Barcelona
Seoul National University Bundang Hospital
Institute for Health Metrics and Evaluation
Beijing Friendship Hospital, Capital Medical University
Universite de Kinshasa
Hasanuddin University
Kementerian Kesehatan Republik Indonesia
The Aga Khan University
University of Washington School of Medicine
The Kirby Institute
Lagos State University
Rollins School of Public Health
Kumamoto University
Imperial College Faculty of Medicine
University of Washington
Hospital de Clinicas de Porto Alegre
Sechenov First Moscow State Medical University
UNICEF
Bangabandhu Sheikh Mujib Medical University
The City University of New York
Jawaharlal Institute of Postgraduate Medical Education and Research
Escuela de Medicina y Ciencias de la Salud TecSalud
Johns Hopkins University School of Medicine
Fatima University Medical Center
National Liver Institute
Coalition for Global Hepatitis Elimination
Indonesian Academy of Sciences
Cardinal Santos Medical Center
Faculty of Tropical Medicine, Mahidol University
Mahidol Oxford Tropical Medicine Research Unit
St. Paul‘s Hospital Millennium Medical College
The National Medical Research Center of Phthisiopulmonology and Infectious Diseases under the Ministry of Health of the Russian Federation
Haiphong University
Instituto de Salud Global de Barcelona
Seoul National University Bundang Hospital
Institute for Health Metrics and Evaluation
Beijing Friendship Hospital, Capital Medical University
Universite de Kinshasa
Hasanuddin University
Kementerian Kesehatan Republik Indonesia
The Aga Khan University
University of Washington School of Medicine
The Kirby Institute
Lagos State University
Rollins School of Public Health
Kumamoto University
Imperial College Faculty of Medicine
University of Washington
Hospital de Clinicas de Porto Alegre
Sechenov First Moscow State Medical University
UNICEF
Bangabandhu Sheikh Mujib Medical University
The City University of New York
Jawaharlal Institute of Postgraduate Medical Education and Research
Escuela de Medicina y Ciencias de la Salud TecSalud
Johns Hopkins University School of Medicine
Fatima University Medical Center
National Liver Institute
Coalition for Global Hepatitis Elimination
Indonesian Academy of Sciences
Cardinal Santos Medical Center
Corresponding Author(s)
Other Contributor(s)
Abstract
The top 20 highest burdened countries (in disability-adjusted life years) account for more than 75% of the global burden of viral hepatitis. An effective response in these 20 countries is crucial if global elimination targets are to be achieved. In this update of the Lancet Gastroenterology & Hepatology Commission on accelerating the elimination of viral hepatitis, we convene national experts from each of the top 20 highest burdened countries to provide an update on progress. Although the global burden of diseases is falling, progress towards elimination varies greatly by country. By use of a hepatitis elimination policy index conceived as part of the 2019 Commission, we measure countries' progress towards elimination. Progress in elimination policy has been made in 14 of 20 countries with the highest burden since 2018, with the most substantial gains observed in Bangladesh, India, Indonesia, Japan, and Russia. Most improvements are attributable to the publication of formalised national action plans for the elimination of viral hepatitis, provision of publicly funded screening programmes, and government subsidisation of antiviral treatments. Key themes that emerged from discussion between national commissioners from the highest burdened countries build on the original recommendations to accelerate the global elimination of viral hepatitis. These themes include the need for simplified models of care, improved access to appropriate diagnostics, financing initiatives, and rapid implementation of lessons from the COVID-19 pandemic.